CSTLCASTLE BIOSCIENCES INCvs its industry peers
A metric-by-metric comparison of CASTLE BIOSCIENCES INC against SIC 8071 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CSTLThis | $786M#5 | — | 1.7x#2 | 2.3x#2 | 3.7%#3 | -232.4%#4 | -12.4%#3 | -5.1%#4 | -10.2%#2 | 5#1 | 60.2%#3 | — |
| FTRE | $1.8B#1 | — | 3.5x#4 | 0.7x#1 | 1.0%#4 | -200.6%#3 | -32.0%#4 | -188.7%#5 | -61.9%#3 | — | 212.2%#1 | — |
| CDNA | $1.8B#2 | 17.1x#1 | 4.3x#5 | 4.8x#3 | 13.8%#2 | -140.6%#2 | -8.1%#2 | -5.0%#3 | — | — | 176.6%#2 | — |
| BLLN | $1.5B#3 | 156.0x#2 | 3.0x#3 | 5.0x#4 | 100.0%#1 | 117.9%#1 | 5.3%#1 | 1.5%#1 | 60.6%#1 | — | — | — |
| LMRI | $975M#4 | — | 1.6x#1 | — | — | — | — | 0.0%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8071). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-07-31.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice